MYC and cancer: In drug-resistant breast cancer patients MYC is involved in the maintenance of chemotherapy-resistant cancer stem cells by increasing the generation of reactive oxygen species (ROS), metabolic byproducts of aerobic respiration that promote cancer cell growth and proliferation, and in turn, make cancer cells more susceptible to cytotoxicity resulting from additional ROS exposure [27,28].